Company news from the 12/12/06 news brief

December 12 2006

GlaxoSmithKline (GSK) has entered into an agreement to acquire UK developer of next generation of antibody therapies Domantis for $454 ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.